Article: Dendritic and T cell response to influenza is normal in the patients with X-linked agammaglobulinemia

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleDendritic and T cell response to influenza is normal in the patients with X-linked agammaglobulinemia
AuthorsLiu, Y1
Wu, Y1
Lam, KT1
Lee, PPW1
Tu, W1
Lau, YL1 2
Keywordsdendritic cells
IFN-γ
influenza virus
T cells
X-linked agammaglobulinemia
Issue Date2012
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0271-9142
CitationJournal Of Clinical Immunology, 2012, v. 32 n. 3, p. 421-429 [How to Cite?]
DOI: http://dx.doi.org/10.1007/s10875-011-9639-y
AbstractIntroduction: Influenza virus is a potential cause of severe disease in the immunocompromised. X-linked agammaglobulinemia (XLA) is a primary immunodeficiency characterized by the lack of immunoglobulin, B cells, and plasma cells, secondary to mutation in Bruton's tyrosine kinase (Btk) gene. Btk is expressed in both B and dendritic cells (DC). However, little is known about the immune response of DC and T cells to influenza virus in XLA patients. Methods: The in vitro maturation and antigen presenting function of monocyte-derived immature DC (imDC) from 12 XLA patients and 23 age-matched normal controls in response to influenza virus were examined. Influenza virus-specific CD4 and CD8 T cell responses in the patients and controls were further determined after administration of inactivated trivalent influenza vaccine. Results: imDC from XLA patients had normal maturation based on major histocompatibility complex (MHC)-I, MHC-II, CD83 and CD86 expression, and interferon (IFN)-α and interleukin-12 production upon influenza virus stimulation. They also had a normal capacity to induce allogeneic T cell proliferation in response to influenza virus. TIV was well tolerated in XLA patients. Influenza virus-specific CD4 +IFN-γ + and CD8 + IFN-γ + T cells and HLA-A2/M1 58-66-tetramer + CTLs could be induced by TIV in XLA patients, and the levels and duration of maintaining these virus-specific cells in XLA patients are comparable to that in normal controls. Conclusion: We demonstrated for the first time that XLA patients have fully competent DC and T cell immune responses to influenza virus. TIV is safe and could be an option for providing T cell-mediated protection against influenza virus infection in XLA patients. © 2012 The Author(s).
ISSN0271-9142
2011 Impact Factor: 3.077
2011 SCImago Journal Rankings: 0.355
DOIhttp://dx.doi.org/10.1007/s10875-011-9639-y
ISI Accession Number IDWOS:000305982100002
Funding AgencyGrant Number
Research Grants Council of Hong KongHKU768108
HKU 777108M
Area of Excellence program on Influenza
University Grants Committee of the Hong Kong SAR, ChinaAoE/M-12/06
Research Fund for the Control of Infectious Diseases, Diseases of the Food and Health Bureau of the Hong Kong SARHK-09-03-05
Funding Information:

We thank the help from Ms. Winnie Wai Sim Lau to recruit the patients. This work was supported in part by the General Research Fund, Research Grants Council of Hong Kong (HKU768108, HKU 777108M, W. T. and Y.L.L), the Area of Excellence program on Influenza supported by the University Grants Committee of the Hong Kong SAR, China (project no. AoE/M-12/06, Y.L.L. and W. T.), and Research Fund for the Control of Infectious Diseases, Diseases of the Food and Health Bureau of the Hong Kong SAR (HK-09-03-05).

ReferencesReferences in Scopus
GrantsControl of Pandemic and Inter-pandemic Influenza
The Role of Natural Killer Cells in the Pathogenesis of Avian Influenza Virus Infection
DC Field
Value
dc.contributor.authorLiu, Y
dc.contributor.authorWu, Y
dc.contributor.authorLam, KT
dc.contributor.authorLee, PPW
dc.contributor.authorTu, W
dc.contributor.authorLau, YL
dc.date.accessioned2012-05-28T08:18:25Z
dc.date.available2012-05-28T08:18:25Z
dc.date.issued2012
dc.description.abstractIntroduction: Influenza virus is a potential cause of severe disease in the immunocompromised. X-linked agammaglobulinemia (XLA) is a primary immunodeficiency characterized by the lack of immunoglobulin, B cells, and plasma cells, secondary to mutation in Bruton's tyrosine kinase (Btk) gene. Btk is expressed in both B and dendritic cells (DC). However, little is known about the immune response of DC and T cells to influenza virus in XLA patients. Methods: The in vitro maturation and antigen presenting function of monocyte-derived immature DC (imDC) from 12 XLA patients and 23 age-matched normal controls in response to influenza virus were examined. Influenza virus-specific CD4 and CD8 T cell responses in the patients and controls were further determined after administration of inactivated trivalent influenza vaccine. Results: imDC from XLA patients had normal maturation based on major histocompatibility complex (MHC)-I, MHC-II, CD83 and CD86 expression, and interferon (IFN)-α and interleukin-12 production upon influenza virus stimulation. They also had a normal capacity to induce allogeneic T cell proliferation in response to influenza virus. TIV was well tolerated in XLA patients. Influenza virus-specific CD4 +IFN-γ + and CD8 + IFN-γ + T cells and HLA-A2/M1 58-66-tetramer + CTLs could be induced by TIV in XLA patients, and the levels and duration of maintaining these virus-specific cells in XLA patients are comparable to that in normal controls. Conclusion: We demonstrated for the first time that XLA patients have fully competent DC and T cell immune responses to influenza virus. TIV is safe and could be an option for providing T cell-mediated protection against influenza virus infection in XLA patients. © 2012 The Author(s).
dc.description.grantControl of Pandemic and Inter-pandemic Influenza
dc.description.grantThe Role of Natural Killer Cells in the Pathogenesis of Avian Influenza Virus Infection
dc.description.grantcode97655
dc.description.grantcode98640
dc.description.naturepublished_or_final_version
dc.description.otherSpringer Open Choice, 28 May 2012
dc.identifier.citationJournal Of Clinical Immunology, 2012, v. 32 n. 3, p. 421-429 [How to Cite?]
DOI: http://dx.doi.org/10.1007/s10875-011-9639-y
dc.identifier.citeulike10314649
dc.identifier.doihttp://dx.doi.org/10.1007/s10875-011-9639-y
dc.identifier.eissn1573-2592
dc.identifier.epage429
dc.identifier.hkuros200821
dc.identifier.isiWOS:000305982100002
Funding AgencyGrant Number
Research Grants Council of Hong KongHKU768108
HKU 777108M
Area of Excellence program on Influenza
University Grants Committee of the Hong Kong SAR, ChinaAoE/M-12/06
Research Fund for the Control of Infectious Diseases, Diseases of the Food and Health Bureau of the Hong Kong SARHK-09-03-05
Funding Information:

We thank the help from Ms. Winnie Wai Sim Lau to recruit the patients. This work was supported in part by the General Research Fund, Research Grants Council of Hong Kong (HKU768108, HKU 777108M, W. T. and Y.L.L), the Area of Excellence program on Influenza supported by the University Grants Committee of the Hong Kong SAR, China (project no. AoE/M-12/06, Y.L.L. and W. T.), and Research Fund for the Control of Infectious Diseases, Diseases of the Food and Health Bureau of the Hong Kong SAR (HK-09-03-05).

dc.identifier.issn0271-9142
2011 Impact Factor: 3.077
2011 SCImago Journal Rankings: 0.355
dc.identifier.issue3
dc.identifier.openurl
dc.identifier.scopuseid_2-s2.0-84862812060
dc.identifier.spage421
dc.identifier.urihttp://hdl.handle.net/10722/147117
dc.identifier.volume32
dc.languageEng
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0271-9142
dc.publisher.placeUnited States
dc.relation.ispartofJournal of Clinical Immunology
dc.relation.referencesReferences in Scopus
dc.rightsThe Author(s)
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
dc.subjectdendritic cells
dc.subjectIFN-γ
dc.subjectinfluenza virus
dc.subjectT cells
dc.subjectX-linked agammaglobulinemia
dc.titleDendritic and T cell response to influenza is normal in the patients with X-linked agammaglobulinemia
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong Li Ka Shing Faculty of Medicine
  2. The University of Hong Kong